ARDS - Aridis Pharmaceuticals gains on withdrawal of public offering of common stock
- Aridis Pharmaceuticals ( NASDAQ: ARDS ) withdraws its proposed public offering of shares of its common stock due to to adverse market conditions.
-
"Due to the current market environment and in the interest of achieving the best value for our stockholders, we have decided to withdraw our recently announced public offering of common stock and focus on executing our clinical development plans," said Vu Truong, CEO of Aridis.
-
The company on Monday, announced proposed public stock offering .
-
Shares are trading up 9.28% premarket.
For further details see:
Aridis Pharmaceuticals gains on withdrawal of public offering of common stock